AKERO Trademark

Trademark Overview

On Wednesday, August 22, 2018, a trademark application was filed for AKERO with the United States Patent and Trademark Office. The USPTO has given the AKERO trademark a serial number of 88088292. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by Akero Therapeutics, Inc.. The AKERO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders
akero

General Information

Serial Number88088292
Word MarkAKERO
Filing DateWednesday, August 22, 2018
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6901415
Registration DateTuesday, November 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 30, 2018
Primary Code005
First Use Anywhere DateTuesday, March 15, 2022
First Use In Commerce DateTuesday, May 31, 2022

Trademark Owner History

Party NameAkero Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAkero Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAkero Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, October 13, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 12, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 30, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 27, 2022USE AMENDMENT FILED
Tuesday, September 27, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, March 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2022SOU EXTENSION 5 GRANTED
Friday, March 25, 2022SOU EXTENSION 5 FILED
Friday, March 25, 2022TEAS EXTENSION RECEIVED
Wednesday, December 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2021SOU EXTENSION 4 GRANTED
Thursday, September 16, 2021SOU EXTENSION 4 FILED
Thursday, September 16, 2021TEAS EXTENSION RECEIVED
Tuesday, March 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 26, 2021SOU EXTENSION 3 GRANTED
Friday, March 26, 2021SOU EXTENSION 3 FILED
Friday, March 26, 2021TEAS EXTENSION RECEIVED
Friday, November 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 20, 2020CORRECTED NOA E-MAILED
Thursday, November 19, 2020SOU EXTENSION 2 GRANTED
Monday, September 28, 2020SOU EXTENSION 2 FILED
Thursday, November 19, 2020DIVISIONAL PROCESSING COMPLETE
Monday, September 28, 2020DIVISIONAL REQUEST RECEIVED
Thursday, November 19, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 28, 2020TEAS EXTENSION RECEIVED
Monday, September 28, 2020TEAS REQUEST TO DIVIDE RECEIVED
Saturday, March 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 26, 2020SOU EXTENSION 1 GRANTED
Thursday, March 26, 2020SOU EXTENSION 1 FILED
Thursday, March 26, 2020TEAS EXTENSION RECEIVED
Thursday, March 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 19, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019ASSIGNED TO LIE
Monday, June 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 13, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, December 13, 2018PRIORITY ACTION E-MAILED
Thursday, December 13, 2018PRIORITY ACTION WRITTEN
Friday, December 7, 2018ASSIGNED TO EXAMINER
Thursday, August 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 25, 2018NEW APPLICATION ENTERED

Related Keywords

akero fibrosis diseases disorders liver steatohepatitis other preparations pharmaceutical related treatment